Skip to content

Clinical trials

Completed Carcinoma, Non-Small-Cell Lung trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Completed Country / region: Canada Clear all

287 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20015
20024
20037
200410
200514
200622
200712
20089
200916
201015
201111
201211
20137
201416
201518
201615
201718
201815
201916
20208
20219
20224
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed287

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb16
Eli Lilly and Company15
Pfizer15
AstraZeneca14
Novartis Pharmaceuticals14
Hoffmann-La Roche13
University Health Network, Toronto13
NCIC Clinical Trials Group11
Alliance for Clinical Trials in Oncology10
GlaxoSmithKline9

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung287
Lung Neoplasms85
Neoplasms34
Melanoma18
Breast Neoplasms16
Colorectal Neoplasms15
Adenocarcinoma of Lung13
Squamous Cell Carcinoma of Head and Neck12
Carcinoma, Renal Cell11
Neoplasm Metastasis11

Trials

Showing 1 to 25 of 287. Each trial links to its page on Pharma Observatory.

187 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.